Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: Efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution

  1. Antolín, S.
  2. Acea, B.
  3. Albaina, L.
  4. Concha, Á.
  5. Santiago, P.
  6. García-Caballero, T.
  7. Mosquera, J.J.
  8. Varela, J.R.
  9. Soler, R.
  10. Calvo, L.
Revista:
Breast Cancer: Targets and Therapy

ISSN: 1179-1314

Ano de publicación: 2019

Volume: 11

Páxinas: 29-42

Tipo: Artigo

DOI: 10.2147/BCTT.S179750 GOOGLE SCHOLAR lock_openAcceso aberto editor HANDLE: https://hdl.handle.net/20.500.11940/15371 HANDLE: https://hdl.handle.net/10347/21394
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela: lock_openAcceso aberto Handle

Obxectivos de Desenvolvemento Sustentable

Fonte de datos: Scopus